- Author:
Yi Sun FAN
1
;
Cheng LIU
2
;
Hui Juan ZHU
3
;
Yi DING
4
;
Wan Jie ZENG
1
;
Xu Fang YIN
1
;
Shuang Shuang DING
1
;
Jun ZHANG
5
Author Information
- Publication Type:Letter
- MeSH: Antibodies, Neutralizing; immunology; Base Sequence; Caliciviridae Infections; diagnosis; virology; Case-Control Studies; Cell Line; DNA Primers; Enzyme-Linked Immunosorbent Assay; Gastroenteritis; diagnosis; virology; Humans; Norovirus; immunology; isolation & purification; Polymerase Chain Reaction; methods; Sensitivity and Specificity
- From: Biomedical and Environmental Sciences 2015;28(3):219-221
- CountryChina
- Language:English
- Abstract: Because of limited viral replication and lack of cytopathic effect in cell culture, a new PCR-based rapid seroneutralization assay for detection of GII.4 norovirus neutralized antibodies was developed with serum samples from acute-phase patients, convalescent-phase patients and healthy controls. According to this study, neutralizing antibodies were detected in 100% of convalescent-phase sera, and in 2.5% of healthy controls sera. However, all of the acute-phase serum samples could not neutralize virus efficiently. Compared to the results from ELISA (96.2% at sensitivity and 80% at specificity), the present in vitro neutralization assay is more specific and more sensitive.